High-dose cytosine arabinoside and mitoxantrone in high-risk acute nonlymphoblastic leukemia. 1987

M A Sanz, and J Martínez, and D Borrego, and G Martín-Aragonés, and I Lorenzo, and G Sanz, and M J Sayas, and I Jarque, and E Pastor, and J Rafecas

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008942 Mitoxantrone An anthracenedione-derived antineoplastic agent. Mitozantrone,CL-232325,DHAQ,Mitoxantrone Acetate,Mitoxantrone Hydrochloride,Mitroxone,NSC-279836,NSC-287836,NSC-299195,NSC-301739,NSC-301739D,Novantron,Novantrone,Onkotrone,Pralifan,Ralenova,Acetate, Mitoxantrone,CL 232325,CL232325,Hydrochloride, Mitoxantrone,NSC 279836,NSC 287836,NSC 299195,NSC 301739,NSC 301739D,NSC279836,NSC287836,NSC299195,NSC301739,NSC301739D
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute

Related Publications

M A Sanz, and J Martínez, and D Borrego, and G Martín-Aragonés, and I Lorenzo, and G Sanz, and M J Sayas, and I Jarque, and E Pastor, and J Rafecas
August 1988, Cancer,
M A Sanz, and J Martínez, and D Borrego, and G Martín-Aragonés, and I Lorenzo, and G Sanz, and M J Sayas, and I Jarque, and E Pastor, and J Rafecas
April 1990, European journal of haematology,
M A Sanz, and J Martínez, and D Borrego, and G Martín-Aragonés, and I Lorenzo, and G Sanz, and M J Sayas, and I Jarque, and E Pastor, and J Rafecas
January 1990, Cancer,
M A Sanz, and J Martínez, and D Borrego, and G Martín-Aragonés, and I Lorenzo, and G Sanz, and M J Sayas, and I Jarque, and E Pastor, and J Rafecas
March 1987, Blood,
M A Sanz, and J Martínez, and D Borrego, and G Martín-Aragonés, and I Lorenzo, and G Sanz, and M J Sayas, and I Jarque, and E Pastor, and J Rafecas
May 1992, Gan to kagaku ryoho. Cancer & chemotherapy,
M A Sanz, and J Martínez, and D Borrego, and G Martín-Aragonés, and I Lorenzo, and G Sanz, and M J Sayas, and I Jarque, and E Pastor, and J Rafecas
June 1985, Seminars in oncology,
M A Sanz, and J Martínez, and D Borrego, and G Martín-Aragonés, and I Lorenzo, and G Sanz, and M J Sayas, and I Jarque, and E Pastor, and J Rafecas
June 1987, Seminars in oncology,
M A Sanz, and J Martínez, and D Borrego, and G Martín-Aragonés, and I Lorenzo, and G Sanz, and M J Sayas, and I Jarque, and E Pastor, and J Rafecas
February 1987, Onkologie,
M A Sanz, and J Martínez, and D Borrego, and G Martín-Aragonés, and I Lorenzo, and G Sanz, and M J Sayas, and I Jarque, and E Pastor, and J Rafecas
September 1975, Cancer,
M A Sanz, and J Martínez, and D Borrego, and G Martín-Aragonés, and I Lorenzo, and G Sanz, and M J Sayas, and I Jarque, and E Pastor, and J Rafecas
January 1994, Acta haematologica,
Copied contents to your clipboard!